Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

Healthcare: Carl Icahn Fires a Shot at Cigna and Express Scripts’ Planned Tie-Up

  • Broadcast in Finance
Industry Focus

Industry Focus

×  

Follow This Show

If you liked this show, you should follow Industry Focus.
h:899941
s:10924543
archived

Here’s why activist billionaire investor Carl Icahn is telling Cigna shareholders to vote against its purchase of Express Scripts. Also, what Regeneron Pharmaceuticals and bluebird bio's new deal means for investors.

Facebook comments

Available when logged-in to Facebook and if Targeting Cookies are enabled